Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01834716 · ClinicalTrials.gov registry record · NA

Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study

A NA study, sponsored by Mayo Clinic.

Completed
Registry status
NA
Development phase
16
Enrollment target

NCT01834716: Completed NA study, sponsored by Mayo Clinic.

NCT01834716 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 16 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT01834716, a NA study, has completed, sponsored by Mayo Clinic.

COMPLETED
Registry status
NA
Development phase
16 participants
Enrollment target

Study Summary

Researchers are trying to determine if cognitively normal subjects undergoing a moderate aerobic exercise program will accumulate less amyloid-ß (Aβ) concentration in their brain than subjects undergoing a non-aerobic exercise program, and further evaluating the safety and imaging characteristics of florbetapir F 18, the radioactive drug that will allow us to image changes in the brain amyloid-ß (Aβ).

Primary Outcome

The number of subjects retained at 6 month end of study time point.

Interventions

  • BEHAVIORAL Aerobic vs. Non-Aerobic exercise

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2013-04
Est. Completion 2014-12
Phase NA
Mayo Clinic

2,844 total trials

What the finished NCT01834716 record still lists

NCT01834716 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which Aerobic vs. Non-Aerobic exercise is the first listed.

NCT01834716 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01834716 about?

NCT01834716 is a clinical study titled "Exercise in Asymptomatic Pre-Alzheimer's Disease Pilot Study". Researchers are trying to determine if cognitively normal subjects undergoing a moderate aerobic exercise program will accumulate less amyloid-ß (Aβ) concentration in their brain than subjects undergoing a non-aerobic exercise program, and further evaluating the safety and imaging characteristics of...

What is the current status of trial NCT01834716?

This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2013-04. Estimated completion is 2014-12.

What interventions are being tested in trial NCT01834716?

The interventions under investigation include: Aerobic vs. Non-Aerobic exercise (BEHAVIORAL).

Who is sponsoring clinical trial NCT01834716?

This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01834716's enrollment target sits among peer trials

16 1871st of 2000 higher than 120 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01834716, the US trial registry maintained by the National Library of Medicine. NCT01834716 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.